id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-N-2185-0002,FDA,FDA-2014-N-2185,"Letter from FDA CFSAN Office of Nutritional Products, Labeling, and Dietary Supplements to Unilever North America, December 23, 2014",Supporting & Related Material,Reference (internal unless indicated),2014-12-24T05:00:00Z,2014,12,,,2014-12-24T21:40:28Z,,0,0,090000648199247d
FDA-2014-N-2185-0001,FDA,FDA-2014-N-2185,"Letter from the Institute of Medicine of the National Academies to FDA CFSAN, May 5, 2004",Supporting & Related Material,Reference (internal unless indicated),2014-12-24T05:00:00Z,2014,12,,,2014-12-24T21:40:21Z,,0,0,090000648199247c